Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Piper Sandler

1 Analyst Just Raised His Price Target 220% on This Quantum Computing Stock

Piper Sandler’s triple-digit target hike on this quantum computing stock, due to its surging bookings and commercial traction, signals accelerating momentum for this quantum innovator.

Barchart

Stocks Settle Lower on Economic Uncertainty

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH25 ) are down -0.20%, and March E-mini Nasdaq futures...

Barchart

Stocks Climb as Strong US Economic News Eases Growth Concerns

The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.49%. March E-mini S&P futures (ESH25 ) are up +0.35%, and March E-mini Nasdaq futures...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Recover Early Losses as Bond Yields Fall

The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.27%. March E-mini S&P futures (ESH25 ) are down -0.14%, and March E-mini Nasdaq futures...

Barchart

Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?

CAVA Group posted amazing 21% YoY same restaurant sales in Q4, crushing Chipotle's 5.4% and Sweetgreen's 4% comps growth, yet shares fell 10% in reaction.

MarketBeat

Why Salesforce Stock Could Be at Fresh Highs by February

One of the reasons we're so excited about Salesforce is the analysts' coverage of the stock. Just last week, TD Cowen upgraded it to a Buy.

MarketBeat

How Elon Musk built an AI moat around Tesla impervious to DeepSeek’s ‘Sputnik moment’

If anything, potentially less demand for Nvidia’s AI training chips could actually benefit the EV manufacturer.

Fortune

Read news from The Economist, FT, and more,
with one subscription

3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year

Check out these three defensive stocks that Wall Street analysts are upgrading their ratings on in the first few weeks of 2025.

MarketBeat

Why Nike Is on The Verge of a Massive Comeback Rally

The team at Piper Sandler just upgraded their rating on Nike from Neutral to Overweight, setting a fresh price target of $90.

MarketBeat

Stocks Recover on Strength in Health Insurers and Energy Stocks

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH25 ) are up +0.26%, and March E-mini Nasdaq futures...

Barchart

The Latest Analyst Ratings For CME Gr

In the preceding three months, 18 analysts have released ratings for CME Gr (NASDAQ:CME), presenting a wide array of perspectives from bullish to bearish.

Benzinga

What 16 Analyst Ratings Have To Say About Murphy Oil

During the last three months, 16 analysts shared their evaluations of Murphy Oil (NYSE:MUR), revealing diverse outlooks from bullish to bearish.

Benzinga

Decoding 23 Analyst Evaluations For HubSpot

Providing a diverse range of perspectives from bullish to bearish, 23 analysts have published ratings on HubSpot (NYSE:HUBS) in the last three months.

Benzinga

Critical Insights From Ulta Beauty Analyst Ratings: What You Need To Know

Ratings for Ulta Beauty (NASDAQ:ULTA) were provided by 28 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential

With the growing demand for cutting-edge therapies reshaping the healthcare landscape, here are two “Strong Buy”-rated biotech stocks with significant potential upside.

Benzinga

DocuSign Stock Jumps On Strong Q3, Analysts Await Proof Of Sustained Growth

DocuSign stock climbed on better-than-expected Q3 results and strong guidance for Q4 and fiscal 2025, leading to price target increases from analysts.

Benzinga

Ulta Beauty Posts Upbeat Results, Joins Asana, Lululemon, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points on Friday.

Benzinga

Expert Outlook: Wells Fargo Through The Eyes Of 14 Analysts

Throughout the last three months, 14 analysts have evaluated Wells Fargo (NYSE:WFC), offering a diverse set of opinions from bullish to bearish.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

A Glimpse Into The Expert Outlook On Robinhood Markets Through 28 Analysts

Robinhood Markets (NASDAQ:HOOD) underwent analysis by 28 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Lululemon Athletica To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

What 9 Analyst Ratings Have To Say About Cracker Barrel Old

Throughout the last three months, 9 analysts have evaluated Cracker Barrel Old (NASDAQ:CBRL), offering a diverse set of opinions from bullish to bearish.

Benzinga

What Analysts Are Saying About Oracle Stock

Oracle (NYSE:ORCL) has been analyzed by 31 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Beyond The Numbers: 11 Analysts Discuss Adobe Stock

In the preceding three months, 11 analysts have released ratings for Adobe (NASDAQ:ADBE), presenting a wide array of perspectives from bullish to bearish.

Benzinga

Evaluating Amerant Bancorp: Insights From 5 Financial Analysts

Throughout the last three months, 5 analysts have evaluated Amerant Bancorp (NYSE:AMTB), offering a diverse set of opinions from bullish to bearish.

Benzinga

Marvell Technology Posts Solid Q3 Beat: Analysts Raise Forecasts, Expect 40%-50% Earnings Growth

Marvell Technology reported upbeat earnings amid exciting earnings season. Analysts raised their price targets, expecting strong growth.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.